Bone Marrow Study on Clonal Hematopoiesis

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Recruiting Observational Study
Osteoporosis Osteoarthritis, Hip Hip Fractures Clonal Hematopoiesis of Indeterminate Potential Aging
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
24 (estimated)
Sponsor
Imelda Hospital, Bonheiden · Other
Who this trial is looking for

This trial is looking for older adults, 65 years and above, who are having hip surgery. Participants will provide blood and bone marrow samples for research on certain genetic changes and their effects.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 65 years old or older

You may not be able to join if

  • I have a known blood condition like leukemia or cancer
  • I am unable to provide written informed consent

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 65 years and older Exclusion Criteria: * known haematological condition (myelodysplasia, leukemia, cancer) * inability to provide written informed consent
Contacts

Michaël R. Laurent, MD PhD

+32485143267

michael.laurent@imelda.be

CONTACT